Group B Strep is the leading cause of severe infection in newborn babies in the UK. Our one-day virtual conference will bring together leading experts to talk about group B Strep, prevention policies, testing options, antibiotic usage, and the progress towards a GBS vaccine.

TOPICS COVERED

• Presentations
• Panel discussions with Q&A
• Short communications from selected abstract submissions (see here)
• Conference Chairs will be Dr Edward Morris (Regional Medical Director, East of England, Immediate Past President of the Royal College of Obstetricians and Gynaecologists and Chair of Trustees for Group B Strep Support) & Professor Philip Steer (Emeritus Professor of Obstetrics at Imperial College. London. Past President of the British Association of Perinatal Medicine and the section of O&G of the Royal Society of Medicine. Chair of the Group B Strep Support Medical Advisory Panel).

WHO SHOULD ATTEND?

• Anyone with an interest in group B Strep and maternity and neonatal care, including:
• Obstetricians
• Microbiologists
• Midwives
• Neonatologists
• Paediatricians
• Public Health Specialists
• GPs
• All Health Professionals
• Clinical Negligence Specialists
• Other interested people

SPEAKERS

• Dr Carol J Baker, Professor of Pediatrics, McGovern Medical School, University of Texas. 2019 Albert B. Sabin Gold Medal recipient. Known as “the Godmother of Group B Strep prevention.”
• Dr Edward Morris, Regional Medical Director, East of England, Immediate Past President of the Royal College of Obstetricians and Gynaecologists.
• Dr Theresa Lamagni, Senior Epidemiologist, Healthcare-Associated Infection & Antimicrobial Resistance, UKHSA.
• Dr Caroline Trotter, Honorary Epidemiologist at UKHSA & Director of the Cambridge-Africa Programme.
• Professor Paul Heath, Professor of Paediatric Infectious Diseases, St George’s University of London & St George’s University Hospitals NHS Trust, London.
• Dr Jim Gray, Consultant Microbiologist, Birmingham Women’s & Children’s NHS Foundation Trust.
• Professor Jane Daniels, Professor of Clinical Trials, University of Nottingham Clinical Trials Unit, Chief Investigator for the GBS3 trial.

The conference will be recorded, and the recordings will be available to those who register.
Tickets are available at a discounted early-bird rate until 17 April 2023.

For more information, please contact: [email protected]